Association of the Risk for Thrombotic Thrombocytopenia Syndrome and Exposure To COVID-19 Vaccines
Clinical trial NCT05252442 · COMPLETED
Trial details
- NCT number
- NCT05252442
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-01
- Primary completion
- 2023-07-11
- Enrollment
- 7641136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.